|
ZNF614 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 2.98140000465352E-08 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
2.18739999446882E-08 |
| Normal-vs-Stage2 |
3.42520000029545E-07 |
| Normal-vs-Stage3 |
2.436200E-02 |
| Normal-vs-Stage4 |
1.179520E-04 |
| Stage1-vs-Stage2 |
5.291600E-01 |
| Stage1-vs-Stage3 |
1.878570E-01 |
| Stage1-vs-Stage4 |
7.606000E-01 |
| Stage2-vs-Stage3 |
1.535240E-01 |
| Stage2-vs-Stage4 |
9.999600E-01 |
| Stage3-vs-Stage4 |
3.454800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
9.72930003229067E-09 |
| Normal-vs-AfricanAmerican |
4.376500E-04 |
| Normal-vs-Asian |
1.184040E-01 |
| Caucasian-vs-AfricanAmerican |
1.996390E-01 |
| Caucasian-vs-Asian |
3.111800E-01 |
| AfricanAmerican-vs-Asian |
6.510000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
7.3416994705866E-10 |
| Normal-vs-Female |
1.308330E-02 |
| Male-vs-Female |
7.77780000000838E-05 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
8.019500E-03 |
| Normal-vs-Extreme_Weight |
2.12829753820643E-12 |
| Normal-vs-Obese |
1.77554999999385E-05 |
| Normal-vs-Extreme_Obese |
1.991260E-04 |
| Normal_Weight-vs-Extreme_Weight |
1.782270E-02 |
| Normal_Weight-vs-Obese |
5.008400E-01 |
| Normal_Weight-vs-Extreme_Obese |
3.208000E-01 |
| Extreme_Weight-vs-Obese |
1.591820E-02 |
| Extreme_Weight-vs-Extreme_Obese |
7.120800E-01 |
| Obese-vs-Extreme_Obese |
4.082400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
6.639500E-04 |
| Normal-vs-Age(41-60Yrs) |
1.44479999997227E-06 |
| Normal-vs-Age(61-80Yrs) |
2.21360000329796E-08 |
| Normal-vs-Age(81-100Yrs) |
1.98351999999291E-05 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
9.956400E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
4.163800E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
3.090800E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
2.200200E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
1.933400E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
6.465200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
5.99849947491293E-10 |
| Normal-VS-Type2 PRCC |
3.17030000029916E-07 |
| Normal-VS-KIRP CIMP |
6.576700E-03 |
| Normal-VS-Unclassified PRCC |
2.804000E-04 |
| Type1 PRCC-VS-Type2 PRCC |
6.699000E-01 |
| Type1 PRCC-VS-KIRP CIMP |
2.915400E-01 |
| Type1 PRCC-VS-Unclassified PRCC |
1.691040E-01 |
| Type2 PRCC-VS-KIRP CIMP |
5.260400E-01 |
| Type2 PRCC-VS-Unclassified PRCC |
4.594600E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
8.478200E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
8.87280249273203E-11 |
| Normal-vs-N1 |
1.362240E-01 |
| Normal-vs-N2 |
3.86849996480976E-09 |
| N0-vs-N1 |
4.418100E-02 |
| N0-vs-N2 |
2.000800E-01 |
| N1-vs-N2 |
1.560460E-03 |
|
|
